{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:14Z","timestamp":1792118354797,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10549-021-06226-3","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T06:02:31Z","timestamp":1619157751000},"page":"501-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up"],"prefix":"10.1007","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7866-2042","authenticated-orcid":false,"given":"Lucie","family":"Veron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-805X","authenticated-orcid":false,"given":"Delphine","family":"Wehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Annerose-Z\u00e9phir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voichita","family":"Suciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-9165","authenticated-orcid":false,"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-7199","authenticated-orcid":false,"given":"Barbara","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-779X","authenticated-orcid":false,"given":"Dan","family":"Chaltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9904-3040","authenticated-orcid":false,"given":"Patricia","family":"Pautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"6226_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"6226_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-70197-4_11","volume":"173","author":"L Streicher","year":"2018","unstructured":"Streicher L, Simon JA (2018) Sexual function post-breast cancer. Cancer Treat Res 173:167\u2013189. https:\/\/doi.org\/10.1007\/978-3-319-70197-4_11","journal-title":"Cancer Treat Res"},{"key":"6226_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/gme.0b013e31826560da","volume":"20","author":"J Baumgart","year":"2013","unstructured":"Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 20:162\u2013168. https:\/\/doi.org\/10.1097\/gme.0b013e31826560da","journal-title":"Menopause"},{"key":"6226_CR4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/jnci\/dji250","volume":"97","author":"PE Goss","year":"2005","unstructured":"Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ et al (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA17. J Natl Cancer Inst 97:1262\u20131271. https:\/\/doi.org\/10.1093\/jnci\/dji250","journal-title":"J Natl Cancer Inst"},{"key":"6226_CR5","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/jnci\/djm246","volume":"99","author":"R Jakesz","year":"2007","unstructured":"Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E et al (2007) Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian breast and colorectal cancer study group trial 6a. J Natl Cancer Inst 99:1845\u20131853. https:\/\/doi.org\/10.1093\/jnci\/djm246","journal-title":"J Natl Cancer Inst"},{"key":"6226_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J et al (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol Off J Am Soc Clin Oncol 28:509\u2013518. https:\/\/doi.org\/10.1200\/JCO.2009.23.1274","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"6226_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12282-017-0764-1","volume":"24","author":"C Koga","year":"2017","unstructured":"Koga C, Akiyoshi S, Ishida M, Nakamura Y, Ohno S, Tokunaga E (2017) Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer Tokyo Jpn 24:714\u2013719. https:\/\/doi.org\/10.1007\/s12282-017-0764-1","journal-title":"Breast Cancer Tokyo Jpn"},{"key":"6226_CR8","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","volume":"22","author":"L Fallowfield","year":"2004","unstructured":"Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22:4261\u20134271. https:\/\/doi.org\/10.1200\/JCO.2004.08.029","journal-title":"J Clin Oncol"},{"key":"6226_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12885-017-3580-2","volume":"17","author":"A Oberguggenberger","year":"2017","unstructured":"Oberguggenberger A, Martini C, Huber N, Fallowfield L, Hubalek M, Daniaux M et al (2017) Self-reported sexual health: breast cancer survivors compared to women from the general population - an observational study. BMC Cancer 17:599. https:\/\/doi.org\/10.1186\/s12885-017-3580-2","journal-title":"BMC Cancer"},{"key":"6226_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/NCC.0b013e31819b5a93","volume":"32","author":"Y Hawkins","year":"2009","unstructured":"Hawkins Y, Ussher J, Gilbert E, Perz J, Sandoval M, Sundquist K (2009) Changes in sexuality and intimacy after the diagnosis and treatment of cancer: the experience of partners in a sexual relationship with a person with cancer. Cancer Nurs 32:271\u2013280. https:\/\/doi.org\/10.1097\/NCC.0b013e31819b5a93","journal-title":"Cancer Nurs"},{"key":"6226_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01758","author":"B Pistilli","year":"2020","unstructured":"Pistilli B, Paci A, Ferreira AR, Di Meglio A, Poinsignon V, Bardet A et al (2020) Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk. J Clin Oncol Off J Am Soc Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.19.01758","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"6226_CR12","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1210\/jc.2017-01138","volume":"102","author":"RJ Santen","year":"2017","unstructured":"Santen RJ, Stuenkel CA, Davis SR, Pinkerton JV, Gompel A, Lumsden MA (2017) Managing menopausal symptoms and associated clinical issues in breast cancer survivors. J Clin Endocrinol Metab 102:3647\u20133661. https:\/\/doi.org\/10.1210\/jc.2017-01138","journal-title":"J Clin Endocrinol Metab"},{"key":"6226_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/13697137.2014.899347","volume":"17","author":"S Salvatore","year":"2014","unstructured":"Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M et al (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric J Int Menopause Soc 17:363\u2013369. https:\/\/doi.org\/10.3109\/13697137.2014.899347","journal-title":"Climacteric J Int Menopause Soc"},{"key":"6226_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00404-017-4504-8","volume":"296","author":"A Pieralli","year":"2017","unstructured":"Pieralli A, Bianchi C, Longinotti M, Corioni S, Auzzi N, Becorpi A et al (2017) Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy (VVA) symptoms. Arch Gynecol Obstet 296:973\u2013978. https:\/\/doi.org\/10.1007\/s00404-017-4504-8","journal-title":"Arch Gynecol Obstet"},{"key":"6226_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/13697137.2018.1436538","volume":"21","author":"M Gambacciani","year":"2018","unstructured":"Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M (2018) Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric J Int Menopause Soc 21:148\u2013152. https:\/\/doi.org\/10.1080\/13697137.2018.1436538","journal-title":"Climacteric J Int Menopause Soc"},{"key":"6226_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001542","author":"P Ruanphoo","year":"2020","unstructured":"Ruanphoo P, Bunyavejchevin S (2020) Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial. Menopause N Y N. https:\/\/doi.org\/10.1097\/GME.0000000000001542","journal-title":"Menopause N Y N"},{"key":"6226_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/GME.0000000000000672","volume":"23","author":"T Pagano","year":"2016","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, De Placido S et al (2016) Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and\/or hormonal therapy for breast cancer: a retrospective study. Menopause N Y N 23:1108\u20131113. https:\/\/doi.org\/10.1097\/GME.0000000000000672","journal-title":"Menopause N Y N"},{"key":"6226_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05211-3","author":"AM Quick","year":"2019","unstructured":"Quick AM, Zvinovski F, Hudson C, Hundley A, Evans C, Suresh A et al (2019) Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-019-05211-3","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"6226_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/GME.0000000000000761","volume":"24","author":"M Gambacciani","year":"2017","unstructured":"Gambacciani M, Levancini M (2017) Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause 24:316\u2013319. https:\/\/doi.org\/10.1097\/GME.0000000000000761","journal-title":"Menopause"},{"key":"6226_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00192-019-04051-3","volume":"30","author":"A Tranoulis","year":"2019","unstructured":"Tranoulis A, Georgiou D, Michala L (2019) Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype? Int Urogynecology J 30:1879\u20131886. https:\/\/doi.org\/10.1007\/s00192-019-04051-3","journal-title":"Int Urogynecology J"},{"key":"6226_CR21","doi-asserted-by":"publisher","first-page":"e556","DOI":"10.1016\/j.clbc.2019.04.007","volume":"19","author":"S Jha","year":"2019","unstructured":"Jha S, Wyld L, Krishnaswamy PH (2019) The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis. Clin Breast Cancer 19:e556\u2013e562. https:\/\/doi.org\/10.1016\/j.clbc.2019.04.007","journal-title":"Clin Breast Cancer"},{"key":"6226_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The bethesda system for reporting cervical cytology: definitions criteria and explanatory notes","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur D (2015) The bethesda system for reporting cervical cytology: definitions criteria and explanatory notes, 3rd edn. Springer International Publishing, Cham. https:\/\/doi.org\/10.1007\/978-3-319-11074-5","edition":"3"},{"key":"6226_CR23","volume-title":"Diagnostic cytopathology essentials","author":"G Kocjan","year":"2013","unstructured":"Kocjan G, Gray W, Levine T, Kardum-Skelin I, Vielh P (2013) Diagnostic cytopathology essentials. Elsevier, Amsterdam"},{"key":"6226_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware","year":"1996","unstructured":"Ware J, Kosinski M, Keller SD (1996) A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220\u2013233. https:\/\/doi.org\/10.1097\/00005650-199603000-00003","journal-title":"Med Care"},{"key":"6226_CR25","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1002\/cncr.26739","volume":"118","author":"RE Baser","year":"2012","unstructured":"Baser RE, Li Y, Carter J (2012) Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer 118:4606\u20134618. https:\/\/doi.org\/10.1002\/cncr.26739","journal-title":"Cancer"},{"key":"6226_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jsxm.2019.10.007","volume":"17","author":"CM Meston","year":"2020","unstructured":"Meston CM, Freihart BK, Handy AB, Kilimnik CD, Rosen RC (2020) Scoring and Interpretation of the FSFI: what can be learned from 20 years of use? J Sex Med 17:17\u201325. https:\/\/doi.org\/10.1016\/j.jsxm.2019.10.007","journal-title":"J Sex Med"},{"key":"6226_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0168-6054(97)85882-5","volume":"40","author":"G Amarenco","year":"1997","unstructured":"Amarenco G, Marquis P, Leriche B, Richard F, Zerbib M, Jacquetin B (1997) Une \u00e9chelle sp\u00e9cifique d\u2019\u00e9valuation de la perturbation de la qualit\u00e9 de vie au cours des troubles mictionnels: l\u2019\u00e9chelle Ditrovie. Ann R\u00e9adapt M\u00e9decine Phys 40:21\u201326. https:\/\/doi.org\/10.1016\/S0168-6054(97)85882-5","journal-title":"Ann R\u00e9adapt M\u00e9decine Phys"},{"key":"6226_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001738","author":"AM Quick","year":"2021","unstructured":"Quick AM, Zvinovski F, Hudson C, Hundley A, Evans C, Stephens JA et al (2021) Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy. Menopause. https:\/\/doi.org\/10.1097\/GME.0000000000001738","journal-title":"Menopause"},{"key":"6226_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/GME.0000000000000955","volume":"25","author":"VL Cruz","year":"2018","unstructured":"Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS et al (2018) Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25:21\u201328. https:\/\/doi.org\/10.1097\/GME.0000000000000955","journal-title":"Menopause"},{"key":"6226_CR30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/GME.0000000000001333","volume":"26","author":"CA Politano","year":"2019","unstructured":"Politano CA, Costa-Paiva L, Aguiar LB, Machado HC, Baccaro LF (2019) Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause 26:833\u2013840. https:\/\/doi.org\/10.1097\/GME.0000000000001333","journal-title":"Menopause"},{"key":"6226_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/GME.0000000000001416","volume":"27","author":"MFR Paraiso","year":"2020","unstructured":"Paraiso MFR, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM et al (2020) A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial. Menopause 27:50\u201356. https:\/\/doi.org\/10.1097\/GME.0000000000001416","journal-title":"Menopause"},{"issue":"Suppl 10","key":"6226_CR32","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","volume":"26","author":"FX Bosch","year":"2008","unstructured":"Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L et al (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl 10):K1-16. https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.064","journal-title":"Vaccine"},{"key":"6226_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00520-017-3878-2","volume":"26","author":"DL Barton","year":"2018","unstructured":"Barton DL, Sloan JA, Shuster LT, Gill P, Griffin P, Flynn K et al (2018) Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer Off J Multinatl Assoc Support Care Cancer 26:643\u2013650. https:\/\/doi.org\/10.1007\/s00520-017-3878-2","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"6226_CR34","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00520-017-3960-9","volume":"26","author":"DL Barton","year":"2018","unstructured":"Barton DL, Shuster LT, Dockter T, Atherton PJ, Thielen J, Birrell SN et al (2018) Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance). Support Care Cancer Off J Multinatl Assoc Support Care Cancer 26:1335\u20131343. https:\/\/doi.org\/10.1007\/s00520-017-3960-9","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"6226_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1019953027596","volume":"75","author":"JA Broeckel","year":"2002","unstructured":"Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE (2002) Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 75:241\u2013248","journal-title":"Breast Cancer Res Treat"},{"key":"6226_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10549-015-3499-8","volume":"152","author":"I Bartula","year":"2015","unstructured":"Bartula I, Sherman KA (2015) Development and validation of the female sexual function Index adaptation for breast cancer patients (FSFI-BC). Breast Cancer Res Treat 152:477\u2013488. https:\/\/doi.org\/10.1007\/s10549-015-3499-8","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06226-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06226-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06226-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:16:50Z","timestamp":1744064210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06226-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6226"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06226-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The microablative laser was provided by DEKA. There was no financial support from DEKA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by a French Ethics Committee (2018-A01500-55).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants gave oral consent to the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}